Paul Matteis Stifel Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
26
Avg Return
Past Year
Past Year
27%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
62.5%
Neutral
37.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Medical Care Facilities
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Hold
Maintained
| $77 |
4%
upside
| 2 | – |
–
| 26 Feb ‘26 3 months ago |
|
|
|
Hold
Maintained
| $24 |
13%
upside
| 2 | – |
–
| 26 Feb ‘26 3 months ago |
|
|
|
Hold
Maintained
| $466 |
3%
upside
| 3 | – |
–
| 13 Feb ‘26 4 months ago |
|
|
|
Buy
Maintained
| $40 |
44%
upside
| 2 | +15% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $188 |
18%
upside
| 3 | -0.88% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $35 |
23%
upside
| 2 | +35% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $39 |
108%
upside
| 2 | +46% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Buy
Maintained
| $508 |
77%
upside
| 3 | +12% |
0
%
| 11 Dec ‘25 6 months ago |
|
|
|
Buy
Initiated
| $28 |
0%
upside
| 1 | +51% |
0
%
| 21 Nov ‘25 6 months ago |
|
|
|
Hold
Maintained
| $3 |
228%
upside
| 1 | – |
–
| 17 Nov ‘25 7 months ago |
|
|
|
Hold
Downgraded
| $61 |
10%
upside
| 2 | +0.25% |
0
%
| 6 Nov ‘25 7 months ago |
|
|
|
Buy
Upgraded
| $202 |
2%
upside
| 1 | +20% |
0
%
| 6 Nov ‘25 7 months ago |
|
|
|
Buy
Maintained
| $12 |
684%
upside
| 1 | +103% |
0
%
| 25 Sep ‘25 8 months ago |
|